Medvinbio Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 1.00 M
as on 03-01-2025
- Company Age 5 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -204.52%
(FY 2022)
- Ebitda -115.71%
(FY 2022)
- Net Worth -9.65%
(FY 2022)
- Total Assets %
(FY 2022)
About Medvinbio Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Subhaschandrabose Bhavanam, Manoj Indupuru, Anjan Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TG2019PTC137688
- Company No.
137688
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2019
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medvinbio Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhaschandrabose Bhavanam  | Director | 17-Dec-2019 | Current |
| Manoj Indupuru | Director | 17-Dec-2019 | Current |
| Anjan Reddy | Director | 17-Dec-2019 | Current |
| Chaithanya Indupuru | Director | 17-Dec-2019 | Current |
Financial Performance of Medvinbio Labs.
Medvinbio Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 204.52% decrease in profit. The company's net worth dipped by a decrease of 9.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medvinbio Labs?
Unlock access to Medvinbio Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Great Ruaha Drilling Exports And Imports Private LimitedActive 12 years 5 monthsSubhaschandrabose Bhavanam is a mutual person
- Zotasoft Exports & Imports Private LimitedActive 4 years 1 month
Subhaschandrabose Bhavanam and Manoj Indupuru are mutual person
- Zota Soft Technologies Private LimitedActive 5 years 7 months
Subhaschandrabose Bhavanam and Manoj Indupuru are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medvinbio Labs?
Unlock and access historical data on people associated with Medvinbio Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medvinbio Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medvinbio Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
